Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

El Contrato Escrito: La Herramienta Predilecta

Client Alert

No existe mejor herramienta a una disputa contractual que un documento firmado por las partes en el cual se expongan las obligaciones y acuerdos entre éstas.

Como regla general, los contratos orales son válidos a menos que una ley específica no los permita. Sin embargo, en práctica, un contrato oral es difícil de hacerlo cumplir y está lleno de un sinfín de circunstanciadas legales que complican la aplicabilidad de las supuestas obligaciones de las partes y restringe los remedios jurídicos que se puedan solicitar.

Si la persona o empresa con la cual se está haciendo una relación contractual no quiere poner lo que se acordó por escrito entonces hay que concluir que esta persona o empresa no tiene ningún interés o intención de cumplir con su aparte del acuerdo. Los contratos son como la póliza de seguros de carros, se tienen para quedar protegidos cuando suceda el incidente. Es importante que el contrato refleje todas las prestaciones, obligaciones y acuerdos entre las partes y exponga en blanco y negro las consecuencias de incumplir.

El contrato escrito es la herramienta predilecta para evitar largos litigios, costos legales excesivos y sirve como instrumento persuasivo a la parte que desea infringir la relación contractual a cumplir.

En BMD nos especializamos haciendo contratos. Contáctanos.


Effective December 12, 2024: Key Updates to Ohio Medicaid Rules for CPC and CMC Programs

Ohio Medicaid has amended rules for the Comprehensive Primary Care (CPC) and Comprehensive Maternal Care (CMC) programs, effective December 12, 2024. Key updates include expanded provider eligibility, stricter cultural competency training timelines, new clinical quality metrics, and changes to maternal care requirements.

Ohio Medicaid Extends Timely Filing Deadline Until 2025

The Ohio Department of Medicaid (ODM) recently announced that it is extending its timely filing deadline to February 28, 2025. According to ODM, roughly 2% of providers have contract issues preventing them from meeting the previous timely filing deadline of December 1, 2024.

Another Drug Manufacturer Pursues Rebate Program as 340B Alternative

Some of the nation’s largest drug manufacturers are forging ahead to implement rebate programs for 340B drugs, even after the federal government has called these programs illegal. While it is unclear how these federal courts will rule, this could threaten the sustainability of safety net providers and their patients.

Hurry Up, STOP. . .Has CTA Been Struck Down By Courts?

Following a recent case in Texas, uncertainty has arisen regarding whether clients should file "beneficial owners" reports. This is a result of the Federal Government enjoined from enforcing the CTA. Contact your BMD Member Blake Gerney to find out how this affects you.

DEA and HHS Issue its Third Extension of Telemedicine Flexibilities through 2025

The DEA and U.S. Department of Health and Human Services (HHS) have extended telemedicine flexibilities for prescribing controlled medications through December 31, 2025. This extension builds on temporary exceptions made in 2020 due to COVID-19, allowing providers to prescribe Schedule II-V controlled substances based on a telemedicine evaluation alone. The extension ensures continued patient access to necessary prescriptions and provides time for providers to comply with future regulations.